HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oncology
Meta-analysis
Meta-analysis of pucotenlimab shows improved outcomes across multiple solid tumors
New analysis shows pucotenlimab improves outcomes for several solid tumor types.
This meta-analysis evaluated pucotenlimab (HX008) in patients with gastric, gastroesophageal junction, triple-negative breast cancer, melano…
A new analysis of pucotenlimab shows significantly improved outcomes versus control for patients with gastric cancer, triple-negative breast…
May 1, 2026
Infectious Disease
Sys. Review
Case report of multidrug resistant Myroides odoratimimus infection in a gastric cancer patient
Rare bacteria shows resistance to most common antibiotics
This case report describes a single instance of Myroides odoratimimus infection in a patient with gastric cancer. The study examines the ant…
A single case study reveals a rare urinary infection that resisted 23 out of 24 antibiotics tested in a laboratory setting.
Frontiers
Apr 30, 2026
Rheumatology
Cohort
Postoperative C-reactive protein-to-albumin ratio associated with severe complications after radical gastrectomy
Blood marker levels may link to gastric cancer surgery complications
This retrospective analysis of 200 gastric cancer patients investigated the predictive value of C-reactive protein-to-albumin ratio (CAR) on…
A recent analysis shows that certain protein levels on the third day after surgery may be linked to more severe complications.
Frontiers
Apr 30, 2026
Gastroenterology
Retrospective review suggests preoperative data predicts skeletal muscle loss in gastric cancer patients
Early scans predict muscle loss in gastric cancer patients after surgery
This retrospective cohort study review evaluates a model using routinely available preoperative and early postoperative clinical data to pre…
A new model using routine early data can predict dangerous muscle loss in gastric cancer patients, helping doctors plan better care sooner.
medRxiv
Apr 30, 2026
Primary Care & Family Medicine
Meta-analysis
Umbrella review associates processed meat consumption with higher risks of cancer and chronic disease outcomes.
Processed meat links to higher cancer and heart disease risks
This umbrella review synthesized data from 34 articles and 54 meta-analyses regarding processed meat consumption. It reports associations wi…
Eating more processed meat like bacon or hot dogs increases your risk for serious health problems including cancer and heart disease.
Frontiers
Apr 28, 2026
Oncology
Case-Control
NDRG4 methylation in blood leukocytes associated with gastric cancer risk and prognosis in a case-control study.
Blood test reveals hidden risk factor for stomach cancer survival
This case-control study evaluated methylation of the NDRG4 gene in peripheral blood leukocytes among 310 gastric cancer patients and 300 con…
A simple blood test can now predict stomach cancer risk and how well chemotherapy will work for patients.
Frontiers
Apr 27, 2026
Allergy & Immunology
Sys. Review
Review of combination strategies for digestive system tumors including gastric and colorectal cancer
Unlocking New Ways to Beat Drug Resistance in Digestive Cancers
This review examines theoretical approaches to enhance efficacy in patients with digestive system tumors, including gastric, colorectal, and…
Researchers are finding better ways to combine treatments so drugs keep working longer.
Frontiers
Apr 23, 2026
Oncology
Cohort
Digital Nutritional Care Reduces Malnutrition and Weight Loss in Post-Gastrectomy Gastric Cancer Patients
Digital nutrition care helped patients recover faster after stomach cancer surgery.
This retrospective controlled study of 150 patients after radical gastrectomy compared a structured digital nutritional care model against r…
A digital nutrition program helped patients recover faster after stomach cancer surgery, improving weight and malnutrition rates compared to…
Frontiers
Apr 23, 2026
Oncology
Cohort
Cohort study links ROS-high status to improved prognosis and mTOR sensitivity in stomach adenocarcinoma
New Score Predicts Better Survival in Stomach Cancer
This retrospective cohort study evaluated stomach adenocarcinoma patients using TCGA-STAD and ACRG Cohort data. High residual ROS score was …
A new measurement tool can spot stomach cancer patients who have a hidden weakness that doctors can target with specific drugs.
medRxiv
Apr 23, 2026
Drug Pipeline
Cohort
Patchouli alcohol modulates PXR-Wnt signaling in Helicobacter pylori-associated gastric cancer models
New Hope for Stomach Cancer Prevention
This cohort study in gastric cancer epithelial cells and mouse models found that patchouli alcohol binds PXR and downregulates Wnt/β-catenin…
You wake up with a dull ache in your stomach.
Frontiers
Apr 22, 2026
Oncology
FDA Approval
FDA Approves Ontruzant (trastuzumab-dttb) for HER2-Overexpressing Breast and Gastric Cancers
FDA approves new cancer drug called Ontruzant for certain breast and stomach cancers
Ontruzant (trastuzumab-dttb) is approved for HER2-overexpressing breast cancer and metastatic gastric or gastroesophageal junction adenocarc…
The FDA has approved a new drug called Ontruzant for treating certain breast and stomach cancers. It works for cancers that have too much of…
FDA
Apr 22, 2026
Cardiology
Cohort
Bidirectional Mendelian randomization suggests inverse association between hypertension liability and gastric cancer risk.
Could high blood pressure actually lower your risk of stomach cancer?
This bidirectional Mendelian randomization and retrospective clinical analysis included 45 individuals with gastric cancer cases and non-can…
Genetic evidence suggests a higher risk for high blood pressure might actually lower your risk of developing stomach cancer.
Frontiers
Apr 21, 2026